Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.

Schmitt KC, Reith ME.

Ann N Y Acad Sci. 2010 Feb;1187:316-40. doi: 10.1111/j.1749-6632.2009.05148.x. Review.

PMID:
20201860
2.

Rapid regulation of the dopamine transporter: role in stimulant addiction?

Zahniser NR, Sorkin A.

Neuropharmacology. 2004;47 Suppl 1:80-91. Review.

PMID:
15464127
3.

The dopamine transporter: a vigilant border control for psychostimulant action.

Williams JM, Galli A.

Handb Exp Pharmacol. 2006;(175):215-32. Review.

PMID:
16722238
4.

Regulation of the dopamine transporter by phosphorylation.

Foster JD, Cervinski MA, Gorentla BK, Vaughan RA.

Handb Exp Pharmacol. 2006;(175):197-214. Review.

PMID:
16722237
5.

[The dopamine transporter: characterization and physiopathologic implications].

Thibaut F, Vaugeois JM, Petit M.

Encephale. 1995 Nov-Dec;21(6):445-51. Review. French.

PMID:
8674469
6.

Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.

Pristupa ZB, McConkey F, Liu F, Man HY, Lee FJ, Wang YT, Niznik HB.

Synapse. 1998 Sep;30(1):79-87.

PMID:
9704884
7.

The dopamine transporter proteome.

Torres GE.

J Neurochem. 2006 Apr;97 Suppl 1:3-10. Review.

8.

Regulation of dopamine transporter function and plasma membrane expression by dopamine, amphetamine, and cocaine.

Kahlig KM, Galli A.

Eur J Pharmacol. 2003 Oct 31;479(1-3):153-8. Review.

PMID:
14612146
9.

Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.

Seger D.

Clin Toxicol (Phila). 2010 Aug;48(7):695-708. doi: 10.3109/15563650.2010.516263. Review.

PMID:
20849328
10.

Regulation of dopamine transporter function by protein-protein interactions: new discoveries and methodological challenges.

Eriksen J, Jørgensen TN, Gether U.

J Neurochem. 2010 Apr;113(1):27-41. doi: 10.1111/j.1471-4159.2010.06599.x. Epub 2010 Jan 18. Review.

11.

Rhesus monkey trace amine-associated receptor 1 signaling: enhancement by monoamine transporters and attenuation by the D2 autoreceptor in vitro.

Xie Z, Westmoreland SV, Bahn ME, Chen GL, Yang H, Vallender EJ, Yao WD, Madras BK, Miller GM.

J Pharmacol Exp Ther. 2007 Apr;321(1):116-27. Epub 2007 Jan 18.

12.

Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum.

Loonam TM, Noailles PA, Yu J, Zhu JP, Angulo JA.

Life Sci. 2003 Jun 27;73(6):727-39. Review.

PMID:
12801594
13.

Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.

Miller GM, Yatin SM, De La Garza R 2nd, Goulet M, Madras BK.

Brain Res Mol Brain Res. 2001 Feb 19;87(1):124-43.

PMID:
11223167
15.
16.

Neuroadaptations involved in amphetamine and cocaine addiction.

White FJ, Kalivas PW.

Drug Alcohol Depend. 1998 Jun-Jul;51(1-2):141-53. Review. No abstract available.

PMID:
9716936
17.

Monoamine transporter as a target molecule for psychostimulants.

Sora I, Li B, Fumushima S, Fukui A, Arime Y, Kasahara Y, Tomita H, Ikeda K.

Int Rev Neurobiol. 2009;85:29-33. doi: 10.1016/S0074-7742(09)85003-4. Review.

PMID:
19607959
18.

Trace amine-associated receptor 1 is a modulator of the dopamine transporter.

Xie Z, Miller GM.

J Pharmacol Exp Ther. 2007 Apr;321(1):128-36. Epub 2007 Jan 18.

19.

Regulation of dopamine transporter trafficking by intracellular amphetamine.

Kahlig KM, Lute BJ, Wei Y, Loland CJ, Gether U, Javitch JA, Galli A.

Mol Pharmacol. 2006 Aug;70(2):542-8. Epub 2006 May 9.

Supplemental Content

Support Center